Matisse Capital Shockwave Medical, Inc. Transaction History

Matisse Capital

$205 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$191.17 - $325.63 $20,455 - $34,842	-107 Reduced 0.46%	23,140 $7.54 Million
Q4 2023 Feb 08, 2024	BUY	$160.99 - $215.69 $172,581 - $231,219	1,072 Added 4.83%	23,247 $4.43 Million
Q3 2023 Oct 13, 2023	BUY	$194.33 - $283.97 $539,848 - $788,868	2,778 Added 14.32%	22,175 $4.42 Million
Q2 2023 Aug 02, 2023	BUY	$223.05 - $302.68 $7,583 - $10,291	34 Added 0.18%	19,397 $5.54 Million
Q1 2023 Apr 27, 2023	BUY	$175.41 - $217.92 $1.63 Million - $2.02 Million	9,292 Added 92.26%	19,363 $4.2 Million
Q4 2022 Jan 20, 2023	BUY	$204.38 - $296.82 $2.06 Million - $2.99 Million	10,071 New	10,071 $2.07 Million
Q2 2022 Jul 28, 2022	BUY	$115.91 - $214.48 $41,727 - $77,212	360 Added 3.18%	11,681 $2.23 Million
Q1 2022 Apr 12, 2022	BUY	$127.96 - $207.36 $344,212 - $557,798	2,690 Added 31.17%	11,321 $2.35 Million
Q4 2021 Feb 04, 2022	BUY	$165.13 - $241.83 $89,995 - $131,797	545 Added 6.74%	8,631 $1.54 Million
Q3 2021 Nov 08, 2021	SELL	$163.99 - $235.57 $3,279 - $4,711	-20 Reduced 0.25%	8,086 $1.67 Million
Q2 2021 Aug 11, 2021	SELL	$131.45 - $201.49 $1.01 Million - $1.55 Million	-7,686 Reduced 48.67%	8,106 $1.54 Million
Q1 2021 May 14, 2021	BUY	$92.73 - $142.05 $953,913 - $1.46 Million	10,287 Added 186.87%	15,792 $2.06 Million
Q4 2020 Feb 12, 2021	BUY	$67.44 - $103.72 $99,136 - $152,468	1,470 Added 36.43%	5,505 $570,000
Q3 2020 Nov 04, 2020	BUY	$42.79 - $75.8 $172,657 - $305,853	4,035 New	4,035 $306,000
Q3 2019 Oct 28, 2019	SELL	$29.71 - $55.23 $129,832 - $241,355	-4,370 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$29.73 - $66.02 $129,920 - $288,507	4,370 New	4,370 $249,000

Others Institutions Holding SWAV

# of Institutions

Shares Held

321K

Call Options Held

1.9K

Put Options Held

View Full List

About Shockwave Medical, Inc.

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

More about SWAV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Matisse Capital, based on Form 13F filings with the SEC.

News

Stay updated on Matisse Capital with notifications on news.

Account